In the tumor syndrome tuberous sclerosis (TSC) mTOR is indirectly activated by MAPK-mediated phosphorylation of TSC1 and 2 that alleviates inhibition of mTOR [71]. This evidence concerns the gene MTOR and tuberous sclerosis.